Effect of n-3 and n-6 unsaturated fatty acids on prostate cancer (PC-3) and prostate epithelial (RWPE-1) cells in vitro

Lipids in Health and Disease

Volumn 12, Issue 1, 2013, Pages

  Meng, Hongzhou ^a   Shen, Yuzhen ^a   Shen, Junhui ^b   Zhou, Feng ^a   Shen, Shengrong ^a   Das, Undurti N ^c,d,e  

^a ZHEJIANG UNIVERSITY   (China)

^b TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^c UND Life Sciences   (United States)

^d JAWAHARLAL NEHRU TECHNOLOGICAL UNIVERSITY   (India)

^e GVP College of Engineering Campus   (India)

Author keywords

Cytokines; Free radicals; Lipid peroxidation; Lipoxin A4; n 3 Polyunsaturated fatty acids; n 6 Polyunsaturated fatty acids; Prostate cancer

Indexed keywords

ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; FORMYLPEPTIDE RECEPTOR LIKE 1; GAMMA LINOLENIC ACID; ICOSAPENTAENOIC ACID; INTERLEUKIN 6; LINOLEIC ACID; LINOLENIC ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXICITY; ELECTRON SPIN RESONANCE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; PROSTATE CANCER;

CELL LINE, TUMOR; CHROMATOGRAPHY, GAS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIAL CELLS; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; FREE RADICALS; HUMANS; INTERLEUKIN-6; LIPOXINS; MALE; ORGAN SPECIFICITY; PROSTATE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84886440052     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-12-160     Document Type: Article

References (29)

1. American Cancer Society, Cancer Facts & Figures 2009 Atlanta (GA): American Cancer Society 2009
2. Prostate cancer and inflammation: the evidence. Sfanos KS, De Marzo AM, Histopathology 2012 60 199 215 10.1111/j.1365-2559.2011.04033.x 22212087
3. Epidemiology of cancer of the prostate. Wynder EL, Mabuchi K, Whitmore WF Jr, Cancer 1971 28 344 360 10.1002/1097-0142(197108)28:2<344::AID- CNCR2820280214>3.0.CO;2-# 5109447
4. Modulation of prostate cancer genetic risk by omega-3 and omega-6 fatty acids. Berquin IM, Min Y, Wu R, et al. J Clin Invest 2007 117 1866 1875 10.1172/JCI31494 17607361 (Pubitemid 47036320)
5. Dietary intake of n-3 and n-6 fatty acids and the risk of prostate cancer. Leitzmann MF, Stampfer MJ, Michaud DS, Am J Clin Nutr 2004 80 204 216 15213050
6. A high ratio of dietary n-6/n-3 polyunsaturated fatty acids is associated with increased risk of prostate cancer. Williamsa CD, Whitley BM, Hoyod C, et al. Nutr Res 2011 31 1 8 10.1016/j.nutres.2011.01.002 21310299
7. Dietary habits and prostate cancer prevention: a review of observational studies by focusing on South America. Niclis C, Diaz MD, Eynard AR, et al. Nutr Cancer 2012 64 23 33 10.1080/01635581.2012.630163 22136636
8. Dietary modification of fatty acid and prostaglandin synthesis in the rat: effect of variations in the level of dietary fat. Croft KD, Beilin U, Vandongen R, et al. Biochim Biophys Acta 1984 795 196 207 10.1016/0005-2760(84) 90066-3 6548159 (Pubitemid 14006606)
9. Dietary fatty acids and prevention of hormone-responsive cancer. Rose DP, Proc Soc Exp Biol Med 1997 216 224 233 10.3181/00379727-216-44172 9349691
10. Polyunsaturated fatty acid metabolism in prostate cancer. Berquin IM, Edwards IJ, Kridel SJ, Yong Q, Chen YQ, Cancer Metastasis Rev 2011 30 295 309 10.1007/s10555-011-9299-7 22015690
11. Essential fatty acids and their metabolites as modulators of stem cell biology with reference to inflammation, cancer, and metastasis. Das UN, Cancer Metastasis Rev 2011 30 311 324 10.1007/s10555-011-9316-x 22005953
12. Lipid metabolism in cancer. Santos CR, Schulze A, FEBS J 2012 279 2610 2623 10.1111/j.1742-4658.2012.08644.x 22621751
13. Essential fatty acids enhance free radical generation and lipid peroxidation to induce apoptosis of tumor cells. Das UN, Clin Lipidol 2011 6 463 489 10.2217/clp.11.34
14. The vanilloid capsaicin induces IL-6 secretion in prostate PC-3 cancer cells. Malagarie-Cazenave S, Olea-Herrero N, Vara D, et al. Cytokine 2011 54 330 337 10.1016/j.cyto.2011.03.010 21474332
15. Characterization of the role of IL-6 in the progression of prostate cancer. Chung TDK, Yu JJ, Spiotto MT, et al. Prostate 1999 38 199 207 10.1002/(SICI)1097-0045(19990215)38:3<199::AID-PROS4>3.0.CO;2-H 10068344 (Pubitemid 29054936)
16. Immunohistochemical analysis of IL-6 family of cytokines and their receptors in benign, hyperplastic and malignant human prostate. Royuela M, Ricote M, Parsons MS, et al. J Pathol 2004 202 41 49 10.1002/path.1476 14694520 (Pubitemid 38072844)
17. Resolving inflammation: dual anti-inflammatory and proresolution lipid mediators. Serhan CN, Chiang N, Van Dyke TE, Nat Rev Immunol 2008 8 349 361 10.1038/nri2294 18437155 (Pubitemid 351595216)
18. Das UN, Molecular Basis of Health and Disease New York: Springer 2011
19. Tumoricidal action of cis-unsaturated fatty acids and its relationship to free radicals and lipid peroxidation. Das UN, Cancer Lett 1991 56 235 243 10.1016/0304-3835(91)90008-6 1850658
20. Cytotoxic effects of essential fatty acids (EFA) in mixed cultures of normal and malignant human cells. Begin ME, Das UN, Ells G, Prog Lipid Res 1986 25 573 576
21. Effect of n-6 and n-3 fatty acids on the survival of vincristine sensitive and resistant human cervical carcinoma cells in vitro. Madhavi N, Das UN, Cancer Lett 1994 84 31 41 10.1016/0304-3835(94)90355-7 8076361 (Pubitemid 24260280)
22. Uptake and distribution of cis-unsaturated fatty acids and their effect on free radical generation in normal and tumor cells in vitro. Das UN, Begin ME, Ells G, Horrobin DF, Free Radic Biol Med 1987 3 9 16 10.1016/0891-5849(87) 90033-5 3040539
23. Mechanism of free Zn(2+) enhancing inhibitory effects of EGCG on the growth of PC-3 cells: interactions with mitochondria. Yang J, Yu H, Sun S, Zhang L, Das UN, Ruan H, He G, Shen S, Biol Trace Elem Res 2009 131 298 310 10.1007/s12011-009-8362-5 19326061
24. 4 as anti-inflammatory and proresolution mediator in human parturition. Maldonado-Pérez D, Golightly E, Denison FC, et al. FASEB J 2011 25 569 575 10.1096/fj.10-170340 20959513
25. Analysis of fatty acids by gas chromatography, and its relevance to research on health and nutrition. Seppänen-Laakso T, Laakso I, Hiltunen R, Anal Chim Acta 2002 465 39 62 10.1016/S0003-2670(02)00397-5 (Pubitemid 34879141)
26. Interleukin 6: a candidate mediator of human prostate cancer morbidity. Twillie DA, Eisenbserger MA, Carducci MA, et al. Urology 1995 45 542 549 10.1016/S0090-4295(99)80034-X 7879350
27. Dietary α-linolenic acid increases TNF-α, and decreases IL-6, IL-10 in response to LPS: effects of sesamin on the Δ-5 desaturation of ω-6 and ω-3 fatty acids in mice. Chavali SR, Zhong WW, Forse RA, Prostaglandins Leukot Essent Fatty Acids 1998 58 185 191 10.1016/S0952-3278(98) 90112-0 9610840 (Pubitemid 28175106)
28. Effect of prostaglandins and their precursors on the proliferation of human lymphocytes and their secretion of tumor necrosis factor and various interleukins. Kumar SG, Das UN, Prostaglandins Leukot Essent Fatty Acids 1994 50 331 334 10.1016/0952-3278(94)90242-9 7938085 (Pubitemid 24195180)
29. Beneficial effect of eicosapentaenoic acid and docosahexaenoic acid in the management of systemic lupus erythematosus and its relationship to the cytokine network. Das UN, Prostaglandins Leukot Essent Fatty Acids 1994 51 207 213 10.1016/0952-3278(94)90136-8 7824535 (Pubitemid 24283032)